Literature DB >> 31430371

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.

P G Corrie, A Marshall, P D Nathan, P Lorigan, M Gore, S Tahir, G Faust, C G Kelly, M Marples, S J Danson, E Marshall, S J Houston, R E Board, A M Waterston, J P Nobes, M Harries, S Kumar, A Goodman, A Dalgleish, A Martin-Clavijo, S Westwell, R Casasola, D Chao, A Maraveyas, P M Patel, C H Ottensmeier, D Farrugia, A Humphreys, B Eccles, G Young, E O Barker, C Harman, M Weiss, K A Myers, A Chhabra, S H Rodwell, J A Dunn, M R Middleton.   

Abstract

Entities:  

Year:  2019        PMID: 31430371      PMCID: PMC6938599          DOI: 10.1093/annonc/mdz237

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
Ann Oncol 2018; 29(8): 1843–1852 (doi: 10.1093/annonc/mdy229) In the original article, there was an error in Figure 3. The figure has now been corrected as below in the online version of the article.
  2 in total

1.  Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudes.

Authors:  A Cortellini; A Leonetti; A Catino; P Pizzutillo; B Ricciuti; A De Giglio; R Chiari; P Bordi; D Santini; R Giusti; M De Tursi; D Brocco; F Zoratto; F Rastelli; F Citarella; M Russano; M Filetti; P Marchetti; R Berardi; M Torniai; D Cortinovis; E Sala; C Maggioni; A Follador; M Macerelli; O Nigro; A Tuzi; D Iacono; M R Migliorino; G Banna; G Porzio; K Cannita; M G Ferrara; E Bria; D Galetta; C Ficorella; M Tiseo
Journal:  Clin Transl Oncol       Date:  2019-08-07       Impact factor: 3.405

2.  Involvement of platelet-derived VWF in metastatic growth of melanoma in the brain.

Authors:  Jose R Robador; Manuel J Feinauer; Stefan W Schneider; Frank T Mayer; Christian Gorzelanny; Artur Sacharow; Xiaobo Liu; Anna Berghoff; Maria A Brehm; Daniela Hirsch; Julia Stadler; Sabine Vidal-Y-Si; Ewa Wladykowski; Marisse Asong; Kai Nowak; Marcel Seiz-Rosenhagen; Viktor Umansky; Christian Mess; Klaus Pantel; Frank Winkler; Alexander T Bauer
Journal:  Neurooncol Adv       Date:  2021-11-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.